{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:41:47Z","timestamp":1793407307763,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2018YFA0108600"],"award-info":[{"award-number":["2018YFA0108600"]}]},{"name":"Natural Science Foundation of Beijing Municipality","award":["7182134"],"award-info":[{"award-number":["7182134"]}]},{"DOI":"10.13039\/501100019018","name":"CAMS Initiative for Innovative Medicine","doi-asserted-by":"crossref","award":["2016\u2013I2M\u20131\u2013017"],"award-info":[{"award-number":["2016\u2013I2M\u20131\u2013017"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"crossref","award":["Z181100006218003"],"award-info":[{"award-number":["Z181100006218003"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11102-021-01133-8","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T07:05:15Z","timestamp":1614668715000},"page":"564-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system"],"prefix":"10.1007","volume":"24","author":[{"given":"Shenzhong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2117-7692","authenticated-orcid":false,"given":"Xinjie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"issue":"2","key":"1133_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11102-018-0864-8","volume":"21","author":"A Ben-Shlomo","year":"2018","unstructured":"Ben-Shlomo A, Cooper O (2018) Silent corticotroph adenomas. Pituitary 21(2):183\u2013193","journal-title":"Pituitary"},{"issue":"4","key":"1133_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134(4):521\u2013535","journal-title":"Acta Neuropathol"},{"issue":"10","key":"1133_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382(10):937\u2013950","journal-title":"N Engl J Med"},{"issue":"2","key":"1133_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/cancers12020514","volume":"12","author":"J Trouillas","year":"2020","unstructured":"Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Raverot G, Roncaroli F, Villa C (2020) How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020. Cancers (Basel) 12(2):514","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1133_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol 28(3):228\u2013243","journal-title":"Endocr Pathol"},{"issue":"7","key":"1133_CR6","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M (2019) Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab 104(7):2473\u20132489","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1133_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","volume":"18","author":"O Cooper","year":"2015","unstructured":"Cooper O (2015) Silent corticotroph adenomas. Pituitary 18(2):225\u2013231","journal-title":"Pituitary"},{"issue":"4","key":"1133_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A et al (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26(4):349\u2013355","journal-title":"Endocr Pathol"},{"issue":"1","key":"1133_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.7150\/thno.47525","volume":"11","author":"X Bao","year":"2021","unstructured":"Bao X, Wang G, Yu S, Sun J, He L, Zhao H et al (2021) Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics. Theranostics 11(1):132\u2013146","journal-title":"Theranostics"},{"issue":"2","key":"1133_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10014-017-0307-7","volume":"35","author":"H Nishioka","year":"2018","unstructured":"Nishioka H, Inoshita N (2018) New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol 35(2):57\u201361","journal-title":"Brain Tumor Pathol"},{"issue":"5","key":"1133_CR11","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-2265.2009.03673.x","volume":"72","author":"HY Cho","year":"2010","unstructured":"Cho HY, Cho SW, Kim SW, Shin CS, Park KS, Kim SY (2010) Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf) 72(5):648\u2013653","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1133_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1227\/NEU.0b013e318257c1f0","volume":"71","author":"AG Ioachimescu","year":"2012","unstructured":"Ioachimescu AG, Eiland L, Chhabra VS, Mastrogianakis GM, Schniederjan MJ, Brat D et al (2012) Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery 71(2):296\u2013303; discussion 4","journal-title":"Neurosurgery"},{"issue":"1","key":"1133_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1227\/01.neu.0000429858.96652.1e","volume":"73","author":"A Jahangiri","year":"2013","unstructured":"Jahangiri A, Wagner JR, Pekmezci M, Hiniker A, Chang EF, Kunwar S et al (2013) A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 73(1):8\u201317; discussion \u2013 8","journal-title":"Neurosurgery"},{"issue":"4","key":"1133_CR14","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610\u2013617; discussion 7\u20138","journal-title":"Neurosurgery"},{"issue":"3","key":"1133_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1227\/01.NEU.0000290906.53685.79","volume":"61","author":"S Yamada","year":"2007","unstructured":"Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K, Takano K et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61(3):580\u2013584; discussion 4\u20135","journal-title":"Neurosurgery"},{"issue":"8","key":"1133_CR16","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","volume":"154","author":"H Alahmadi","year":"2012","unstructured":"Alahmadi H, Lee D, Wilson JR, Hayhurst C, Mete O, Gentili F et al (2012) Clinical features of silent corticotroph adenomas. Acta Neurochir (Wien) 154(8):1493\u20131498","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"1133_CR17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1590\/0004-2730000003116","volume":"58","author":"P Marques","year":"2014","unstructured":"Marques P, Mafra M, Calado C, Martins A, Monteiro J, Leite V (2014) Aggressive pituitary lesion with a remarkably high Ki-67. Arq Bras Endocrinol Metabol 58(6):656\u2013660","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"1133_CR18","first-page":"1890","volume":"19","author":"J Liu","year":"2020","unstructured":"Liu J, He Y, Zhang X, Yan X, Huang Y (2020) Clinicopathological analysis of 250 cases of pituitary adenoma under the new WHO classification. Oncol Lett 19(3):1890\u20131898","journal-title":"Oncol Lett"},{"issue":"4","key":"1133_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.nec.2012.06.008","volume":"23","author":"JW Lucas","year":"2012","unstructured":"Lucas JW, Zada G (2012) Endoscopic surgery for pituitary tumors. Neurosurg Clin N Am 23(4):555\u2013569","journal-title":"Neurosurg Clin N Am"},{"issue":"1","key":"1133_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11102-017-0844-4","volume":"21","author":"F Langlois","year":"2018","unstructured":"Langlois F, Lim DST, Yedinak CG, Cetas I, McCartney S, Cetas J et al (2018) Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary 21(1):32\u201340","journal-title":"Pituitary"},{"issue":"2","key":"1133_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12672-010-0014-x","volume":"1","author":"O Cooper","year":"2010","unstructured":"Cooper O, Ben-Shlomo A, Bonert V, Bannykh S, Mirocha J, Melmed S (2010) Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes. Horm Cancer 1(2):80\u201392","journal-title":"Horm Cancer"},{"issue":"1","key":"1133_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","volume":"58","author":"KJ Bradley","year":"2003","unstructured":"Bradley KJ, Wass JA, Turner HE (2003) Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin Endocrinol (Oxf) 58(1):59\u201364","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1133_CR23","first-page":"1039","volume":"104","author":"A Fountas","year":"2018","unstructured":"Fountas A, Lavrentaki A, Subramanian A, Toulis KA, Nirantharakumar K, Karavitaki N (2018) Recurrence in silent corticotroph adenomas after primary treatment: a systematic review and meta-analysis. J Clin Endocrinol Metab 104(4):1039\u201348","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1133_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/cen.14133","volume":"92","author":"L Kasuki","year":"2020","unstructured":"Kasuki L, Antunes X, Coelho MCA, Lamback EB, Galvao S, Silva Camacho AH et al (2020) Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotroph adenomas. Clin Endocrinol (Oxf) 92(2):145\u2013149","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1133_CR25","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/cen.13146","volume":"85","author":"KB Guttenberg","year":"2016","unstructured":"Guttenberg KB, Mayson SE, Sawan C, Kharlip J, Lee JY, Martinez-Lage M et al (2016) Prevalence of clinically silent corticotroph macroadenomas. Clin Endocrinol (Oxf) 85(6):874\u2013880","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1133_CR26","doi-asserted-by":"publisher","first-page":"558593","DOI":"10.3389\/fendo.2020.558593","volume":"11","author":"G Zheng","year":"2020","unstructured":"Zheng G, Lu L, Zhu H, You H, Feng M, Liu X et al (2020) Clinical, laboratory, and treatment profiles of silent corticotroph adenomas that have transformed to the functional type: a case series with a literature review. Front Endocrinol (Lausanne) 11:558593","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1133_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12020-016-1028-0","volume":"56","author":"A Righi","year":"2017","unstructured":"Righi A, Faustini-Fustini M, Morandi L, Monti V, Asioli S, Mazzatenta D et al (2017) The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1\/3. Endocrine 56(2):286\u2013297","journal-title":"Endocrine"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-021-01133-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-021-01133-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-021-01133-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T07:56:53Z","timestamp":1625817413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-021-01133-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1007\/s11102-021-01133-8","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"assertion":[{"value":"8 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No competing financial interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Peking Union Medical College Hospital. Written informed consent was obtained from all the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}